Cargando…
Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence
INTRODUCTION: Although the treatment success of long-term growth hormone therapy (GHT) is dependent on maintaining patients’ adherence to treatment, marked variations in adherence levels among children with GHT (eg, 7–71% nonadherence) have been reported. Barriers to or promoters of GHT adherence ha...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404042/ https://www.ncbi.nlm.nih.gov/pubmed/37545653 http://dx.doi.org/10.2147/PPA.S417142 |
_version_ | 1785085208541790208 |
---|---|
author | Takasawa, Kei Mabe, Hiroyo Nagamatsu, Fusa Amano, Naoko Miyakawa, Yuichi Sutani, Akito Kagawa, Reiko Okada, Satoshi Tanahashi, Yusuke Suzuki, Shigeru Hiroshima, Shota Nagasaki, Keisuke Dateki, Sumito Takishima, Shigeru Takahashi, Ikuko Kashimada, Kenichi |
author_facet | Takasawa, Kei Mabe, Hiroyo Nagamatsu, Fusa Amano, Naoko Miyakawa, Yuichi Sutani, Akito Kagawa, Reiko Okada, Satoshi Tanahashi, Yusuke Suzuki, Shigeru Hiroshima, Shota Nagasaki, Keisuke Dateki, Sumito Takishima, Shigeru Takahashi, Ikuko Kashimada, Kenichi |
author_sort | Takasawa, Kei |
collection | PubMed |
description | INTRODUCTION: Although the treatment success of long-term growth hormone therapy (GHT) is dependent on maintaining patients’ adherence to treatment, marked variations in adherence levels among children with GHT (eg, 7–71% nonadherence) have been reported. Barriers to or promoters of GHT adherence have been discussed and investigated, and digital health technologies, such as electronic GH injection devices, may have the potential to assess adherence to GHT more accurately. Thus, we conducted a multicenter, retrospective cohort study using GH injection log analysis of an electronic GH device, GROWJECTOR(®)L, to qualify adherence and explore the factors influencing adherence. METHODS: This study enrolled 41 patients (median[range] age, 5.8[3.0 ~ 17.0] years) with short stature from nine Japanese medical institutions. The injection log data (12–48 weeks) were read by smartphones and collected into the data center through a cloud server. RESULTS: Although cumulative adherence rates remained higher than 95% throughout the observation period, five (12.2%) patients had low adherence (<85%). Subsequently, subgroup and logistic regression analyses for exploring factors affecting adherence revealed that self-selection of GH device and irregular injection schedule (ie, frequent injections after midnight) significantly affected adherence rate (p=0.034 and 0.048, respectively). In addition, higher rates of irregular injections significantly affected low adherence (median[range], 11.26[0.79 ~ 30.50]% vs 0.26[0.00 ~ 33.33]%, p = 0.029). DISCUSSION: Our study indicated that injection log analysis using an electronic GH device could detect irregular injection schedules due to a night owl or disturbance in lifetime rhythm affecting low adherence and had significant potential to encourage collaborative monitoring of adherence with healthcare providers and patients themselves/caregivers, along with growing autonomy and shared decision-making. Our study suggests the significance of narrative and personal approaches to adherence of patients with GHT and the usefulness of digital devices for such an approach and for removing various barriers to patient autonomy, leading to improvement and maintenance of adherence. |
format | Online Article Text |
id | pubmed-10404042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-104040422023-08-06 Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence Takasawa, Kei Mabe, Hiroyo Nagamatsu, Fusa Amano, Naoko Miyakawa, Yuichi Sutani, Akito Kagawa, Reiko Okada, Satoshi Tanahashi, Yusuke Suzuki, Shigeru Hiroshima, Shota Nagasaki, Keisuke Dateki, Sumito Takishima, Shigeru Takahashi, Ikuko Kashimada, Kenichi Patient Prefer Adherence Original Research INTRODUCTION: Although the treatment success of long-term growth hormone therapy (GHT) is dependent on maintaining patients’ adherence to treatment, marked variations in adherence levels among children with GHT (eg, 7–71% nonadherence) have been reported. Barriers to or promoters of GHT adherence have been discussed and investigated, and digital health technologies, such as electronic GH injection devices, may have the potential to assess adherence to GHT more accurately. Thus, we conducted a multicenter, retrospective cohort study using GH injection log analysis of an electronic GH device, GROWJECTOR(®)L, to qualify adherence and explore the factors influencing adherence. METHODS: This study enrolled 41 patients (median[range] age, 5.8[3.0 ~ 17.0] years) with short stature from nine Japanese medical institutions. The injection log data (12–48 weeks) were read by smartphones and collected into the data center through a cloud server. RESULTS: Although cumulative adherence rates remained higher than 95% throughout the observation period, five (12.2%) patients had low adherence (<85%). Subsequently, subgroup and logistic regression analyses for exploring factors affecting adherence revealed that self-selection of GH device and irregular injection schedule (ie, frequent injections after midnight) significantly affected adherence rate (p=0.034 and 0.048, respectively). In addition, higher rates of irregular injections significantly affected low adherence (median[range], 11.26[0.79 ~ 30.50]% vs 0.26[0.00 ~ 33.33]%, p = 0.029). DISCUSSION: Our study indicated that injection log analysis using an electronic GH device could detect irregular injection schedules due to a night owl or disturbance in lifetime rhythm affecting low adherence and had significant potential to encourage collaborative monitoring of adherence with healthcare providers and patients themselves/caregivers, along with growing autonomy and shared decision-making. Our study suggests the significance of narrative and personal approaches to adherence of patients with GHT and the usefulness of digital devices for such an approach and for removing various barriers to patient autonomy, leading to improvement and maintenance of adherence. Dove 2023-08-01 /pmc/articles/PMC10404042/ /pubmed/37545653 http://dx.doi.org/10.2147/PPA.S417142 Text en © 2023 Takasawa et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Takasawa, Kei Mabe, Hiroyo Nagamatsu, Fusa Amano, Naoko Miyakawa, Yuichi Sutani, Akito Kagawa, Reiko Okada, Satoshi Tanahashi, Yusuke Suzuki, Shigeru Hiroshima, Shota Nagasaki, Keisuke Dateki, Sumito Takishima, Shigeru Takahashi, Ikuko Kashimada, Kenichi Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence |
title | Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence |
title_full | Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence |
title_fullStr | Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence |
title_full_unstemmed | Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence |
title_short | Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence |
title_sort | growth hormone injection log analysis with electronic injection device for qualifying adherence to low-irritant formulation and exploring influential factors on adherence |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404042/ https://www.ncbi.nlm.nih.gov/pubmed/37545653 http://dx.doi.org/10.2147/PPA.S417142 |
work_keys_str_mv | AT takasawakei growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT mabehiroyo growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT nagamatsufusa growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT amanonaoko growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT miyakawayuichi growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT sutaniakito growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT kagawareiko growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT okadasatoshi growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT tanahashiyusuke growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT suzukishigeru growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT hiroshimashota growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT nagasakikeisuke growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT datekisumito growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT takishimashigeru growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT takahashiikuko growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence AT kashimadakenichi growthhormoneinjectionloganalysiswithelectronicinjectiondeviceforqualifyingadherencetolowirritantformulationandexploringinfluentialfactorsonadherence |